Trade Mark Journal No.2026/038 18 September 2026

UK00004425926 4 August 2026 (1,5,9,42,44)

LiquiPath

Class 1
Chemical and biochemical and biological preparations, substances, reagents and solutions; biological preparations for use in industry and science; chemical and biochemical and biological preparations, substances, reagents and solutions for use in and as part of analytical tests and analytical test kits, and including those for diagnostic and molecular diagnostic development and testing; Chemical, biochemical and biological preparations, substances, reagents and solutions for the detection and diagnosis of disease, monitoring organ health, detecting cell and tissue damage, and monitoring drug response; chemical test reagents for biomarkers, other than for medical or veterinary use; all the above being for scientific and industrial purposes.
Class 5
Diagnostic testing materials for medical use; Chemical, biochemical and biological preparations, substances, reagents and solutions for use in and as part of analytical tests and analytical test kits; chemical, biochemical and biological preparations, substances, reagents and solutions for use in and as part of analytical tests and analytical test kits, and including those for diagnostic and molecular diagnostic development and testing; Chemical, biochemical and biological preparations, substances, reagents and solutions for use in and as part of analytical tests and analytical test kits for the purpose of the detection and diagnosis of disease, monitoring organ health, detecting cell and tissue damage, and monitoring drug response; diagnostic biomarker reagents for medical purposes; all the above being for medical and veterinary purposes.
Class 9
Downloadable computer software and application software for use in diagnostic and molecular diagnostic development and testing; artificial intelligence and machine learning software for diagnostic and molecular diagnostic development and testing; downloadable computer software, downloadable computer application software, artificial intelligence software and machine learning software for the detection and diagnosis of disease, monitoring organ health, detecting cell and tissue damage, and monitoring drug response.
Class 42
Laboratory analysis services being scientific research for the purpose of biomarker discovery; laboratory analysis services for diagnostic and molecular diagnostic development and testing; scientific testing services for diagnostic and molecular diagnostic development and testing; biological testing for molecular diagnostic development and testing; research services for diagnostic and molecular diagnostic development and testing; product design services for diagnostic and molecular diagnostic development and testing; product development services for diagnostic and molecular diagnostic development and testing; design and development of software and Software as a Service (SaaS), including software using artificial intelligence and machine learning, relating to diagnostics and molecular diagnostics; Software as a Service (SaaS) including Software as a Service (SaaS) using artificial intelligence and machine learning, for use in relation to the detection and diagnosis of disease, diagnostics and molecular diagnostics, monitoring organ health, detecting cell and tissue damage, and monitoring drug response; biochemical research and analysis; design and development of testing and analysis methods for the detection and diagnosis of disease, monitoring organ health, detecting cell and tissue damage, and monitoring drug response; research and development of medical diagnostic services; design and development of diagnostic biomarker reagents for the detection and treatment of disease, monitoring organ health, detecting cell and tissue damage, and monitoring drug response; discovery and development of biomarkers for detecting disease, monitoring organ health, detecting cell and tissue damage, and monitoring drug response; analysis of data relating to biomarkers; medical, clinical and pre-clinical research, development and analysis services all related to the detection and diagnosis of disease, monitoring organ health, detecting cell and tissue damage, and monitoring drug response; DNA, RNA and protein research, testing and analysis services; research and analysis services relating to analytes; scientific and technological services in the field of bioinformatics; Software as a Service (SaaS), namely, providing bioinformatic and data analysis services.
Class 44
Laboratory analysis services; laboratory analysis services for diagnostic and molecular diagnostic development, testing and analysis; medical testing services and medical analysis services relating to the detection and diagnosis of disease, monitoring organ health, detecting cell and tissue damage, and monitoring drug response; pathology services; pathological examination services for the detection and diagnosis of disease, monitoring organ health, detecting cell and tissue damage, and monitoring drug response; medical diagnostic services; medical laboratory services for the analysis of samples taken from patients; services for testing and analysis of human tissue, human serum, blood and urine for the purpose of detection and diagnosis of disease, monitoring organ health, detecting cell and tissue damage, and monitoring drug response; medical and health analysis services relating to the detection and diagnosis of disease, monitoring organ health, detecting cell and tissue damage, and monitoring drug response; medical and health analysis services relating to DNA, RNA, proteins, genetics and epigenetics; DNA, RNA, and protein testing and analysis services; testing of analytes for diagnostic purposes; analysis of analytes; all the above for the purposes of medical diagnosis and the treatment of people or animals.

Tagomics Ltd

Representative: Venner Shipley LLP